Skip to main content
. 2025 Aug 25;24:263. doi: 10.1186/s12944-025-02681-9

Table 2.

Association of SHR with Hypertension risk (Multiple imputation)

Categories Model 1 Model 2 Model 3 Model 4
HR (95%CI) P value HR (95%CI) P value HR (95%CI) P value HR (95%CI) P-value
SHR 1.50 (1.19–1.89) 0.001 1.45 (1.16–1.83) 0.001 1.44 (1.14–1.81) 0.002 1.48 (1.17–1.88) 0.001
SHR Quartile
 Q1 1(Ref) 1(Ref) 1(Ref) 1(Ref)
 Q2 1.02 (0.89–1.17) 0.779 1.08 (0.92–1.27) 0.341 1.02 (0.89–1.17) 0.759 1.01 (0.88–1.16) 0.843
 Q3 1.03 (0.90–1.18) 0.649 0.98 (0.84–1.16) 0.846 1.01 (0.88–1.16) 0.843 1.00 (0.87–1.15) 0.947
 Q4 1.18 (1.04–1.35) 0.013 1.22 (1.04–1.42) 0.014 1.16 (1.01–1.32) 0.033 1.16 (1.02–1.33) 0.028
P for trend 0.015 0.026 0.042 0.040

Model 1: not adjusted

Model 2: adjusted for sex, age, race, marital status, residence, educational status, sleep duration, smoking status, drinking status, waist circumference, BMI

Model 3: adjusted for model 2, additionally adjusted for cancer, heart diseases, stroke, arthritis, liver diseases, kidney diseases, asthma, and mental health

Model 4: adjusted for model 3, additionally adjusted for creatinine, BUN, UA, HB, HDL, LDL, cystatin C

SHR Stress hyperglycemia ratio, WC Waist circumference, BMI Body mass index, BUN Blood urea nitrogen, UA Uric acid, FBG Fasting blood glucose, HB Hemoglobin, HDL High-Density Lipoprotein, LDL Low-density lipoprotein, HR Hazard ratios, CI Confidence interval